Dr. rer. nat. Simon Völkl

Department of Medicine 5 – Haematology and Oncology

Detection of Signature Double-Negative T Cells Is a Reliable Marker for ALPS Associated with FAS Mutation (2022) Eisenhauer N, Miano M, Naumann-Bartsch N, Leyh J, Terranova P, Hinze C, Aigner M, et al. Conference contribution Early Real Time Quantification of CD19. CAR T Cells By Flow Cytometry As a Predictive Biomarker for Response in Patients with R/R LBCL (2022) Blumenberg V, Busch G, Baumann S, Jitschin R, Winkelmann M, Hellwig K, Rejeski K, et al. Conference contribution Biphasic Neutrophil Recovery after CD19 CART in R/R LBCL Is Associated with Superior PFS/OS, Robust CAR T-Cell Expansion in Relation to Baseline Tumor Volume, and a Decrease of Systemic Inflammation over Time (2022) Rejeski K, Perez AP, Iacoboni G, Buecklein VL, Blumenberg V, Völkl S, Penack O, et al. Conference contribution CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients (2022) Müller F, Völkl S, Mougiakakos D, Böltz S, Aigner M, Gary R, Kretschmann S, et al. Conference contribution Alterations of Immune Cells By Large B Cell Lymphoma Persist Years after Achieving Complete Remission and Correlate with Impaired Adaptive Immunity (2022) Pelzl R, Kübel S, Klein P, Gsottberger F, Wendland K, Petkovic S, Brueckl V, et al. Conference contribution Expression of disialoganglioside GD2 in breast cancer subtypes (2022) Gaß P, Kailayangiri S, Hübner H, Rübner M, Hartmann A, Häberle L, Völkl S, et al. Conference contribution Role of CAR T Cell Metabolism for Therapeutic Efficacy (2022) Rial Saborido J, Völkl S, Aigner M, Mackensen A, Mougiakakos D Journal article, Review article Methodological Establishment of an in-vitro ADCC Assay by using patient-specific Immune Cells (2022) Lehle S, Völkl S, Rübner M, Emons J, Seitz K, Beckmann M, Fasching P, Hübner H Conference contribution, Conference Contribution CAR T Cell Treatment of Refractory Systemic Lupus Erythematosus (2022) Schett G, Böltz S, Müller F, Kleyer A, Völkl S, Aigner M, Gary R, et al. Conference contribution Early Expansion of CD19.CAR-T Cells in vivo identify the Patients at Risk for the Treatment Failure in diffuse large B-Cell Lymphoma (2022) Blumenberg V, Busch G, Baumann S, Jitschin R, Winkelmann M, Hellwig K, Schmidt C, et al. Conference contribution